| Literature DB >> 35585081 |
Anke Langenfeld1, Brigitte Wirth2,3, Andrea Scherer-Vrana2, Fabienne Riner2, Kyra Gaehwiler2, Paola Valdivieso4, B Kim Humphreys2, Felix Scholkmann5,6, Martin Flueck4,7, Petra Schweinhardt2.
Abstract
The aim of our study was (I) To compare back muscle oxygenation and perfusion as well as Biering-Sorensen muscle endurance (BSME) test holding times between chronic non-specific low back pain (CNSLBP) patients and asymptomatic controls matched for age, body mass index (BMI), sex and physical activity, and (II) to investigate factors associated with BSME holding times. Muscle perfusion (tHb) and oxygenation (SmO2) were measured by near-infrared spectroscopy (NIRS) based oximetry in three back muscles during the BSME. Reliability of tHb and SmO2 was assessed in a separate sample. BSME holding time and SmO2 were compared between patients (n = 45) and controls (n = 45) and factors associated with BSME holding time were assessed using multiple linear regression. Reliability for SmO2 was excellent (ICC = 0.87-0.99). THb showed poor to moderate reliability and was not further used. Groups differed for BSME holding time (P = 0.03), pain intensity (P ≤ 0.0005) and subcutaneous tissue thickness (P = 0.01) but not for NIRS measures. Physical activity and BMI were associated with BSME holding times. Insufficient muscle oxygenation does not seem to be a major factor contributing to CNSLBP. Future investigation should evaluate other determinants of BSME holding times, such as motivation and recruitment of auxiliary muscles.Entities:
Mesh:
Year: 2022 PMID: 35585081 PMCID: PMC9117220 DOI: 10.1038/s41598-022-11683-x
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.996
Figure 1Positioning of the test subject and NIRS oximetry devices during the Biering–Sorensen muscle endurance (BSME) test. (b) Schematic representation of the location of M. longissimus, M. iliocostalis and M. multifidus, (c) positioning of the NIRS oximetry devices in the back, (d) close-up of the NIRS oximeter. (d) Visualization of a test subject performing the BSME test.
Test–retest reliability for area under the curve (AUC), Median 1, Median 2, Median 3 for oxygen saturation (SmO2) perfusion (tHb) and recovery time of M. longissimus, M. multifidus and M. iliocostalis.
| ICC | 95% CI | ||
|---|---|---|---|
| LL | UL | ||
| AUC_SmO2_M.iliocostalis | 0.382 | − 0.302 | 0.848 |
| AUC_tHb_M.longissimus | 0.532 | 0.020 | 0.834 |
| AUC_tHb_M.multifidus | 0.500 | − 0.204 | 0.851 |
| AUC_tHb_M.iliocostalis | 0.176 | − 0.772 | 0.800 |
| Median1_ | 0.003 | − 0.631 | 0.694 |
| Median1_tHb_M.longissimus | 0.720 | 0.302 | 0.909 |
| Median1_tHb_M.multifidus | 0.553 | − 0.118 | 0.869 |
| Median1_tHb_M.iliocostalis | 0.195 | − 0.632 | 0.796 |
| Median2_SmO2_M.iliocostalis | 0.253 | − 0.508 | 0.838 |
| Median2_tHb_M.longissimus | 0.511 | − 0.182 | 0.864 |
| Median2_tHb_M.multifidus | 0.556 | − 0.180 | 0.882 |
| Median2_tHb_M.iliocostalis | 0.111 | − 0.965 | 0.819 |
| Median3_SmO2_M.iliocostalis | 0.500 | − 0.389 | 0.894 |
| Median3_tHb_M.longissimus | 0.599 | − 0.043 | 0.885 |
| Median3_tHb_M.multifidus | 0.716 | − 0.032 | 0.946 |
| Median3_tHb_M.iliocostalis | 0.341 | − 0.371 | 0.801 |
| Recovery time_SmO2_M.longissimus | 0.252 | − 0.620 | 0.779 |
| Recovery time_SmO2_M.multifidii | − 0.225 | − 11.511 | 0.998 |
| Recovery time_ SmO2_M.iliocostalis | Incalculable | ||
| Recovery time_tHb_M.longissimus | Incalculable | ||
| Recovery time_tHb_M.multidifii | Incalculable | ||
| Recovery time_tHb_M.liocostalis | Incalculable | ||
Recovery time for SmO2 M. iliocostalis, tHb M. longissimus, tHb M. multifidus and tHb M. iliocostalis could not be calculated due to a high number of missing data. Displayed are the intraclass correlation coefficients (ICC), the 95% confidence intervals (95% CI), lower level (LL) and upper level (UL).
Excellent reliability is highlighted in bold. Based on these results, only the measures for muscle oxygenation (SmO2) in the M. longissimus and M. multifidus were analysed in the main study.
Demographic and clinical characteristics of the final sample including group comparison of the chronic non-specific low back pain (CNSLBP) group and asymptomatic controls.
| Variable | CNSLBP patients (n = 45) | Asymptomatic controls (n = 45) | Group comparison LBP patients and asymptomatic controls ( |
|---|---|---|---|
| Sex (male/female) | 14/31 | 14/31 | |
| Age (years) (mean, (SD)) | 34.02 (12.36) | 33.16 (12.41) | 0.744 (− 6.17, 4.44) |
| Height (cm) (mean, (SD)) | 170.44 (10.20) | 170.24. (7.76) | 0.910 (− 3.90, 3.48) |
| Weight (kg) (mean, (SD)) | 67.47 (11.68) | 65.19 (9.84) | 0.288 (− 6.55, 1.99) |
| BMI (mean, (SD)) | 23.16 (3.13) | 22.40 (2.29) | 0.197 (− 1.91, 0.40) |
| Subcutaneous tissue thickness (mm) (mean, (SD)) | 8.98 (2.76) | 7.58 (2.39) | |
| Pain intensity (mean, (SD)) | 2.78 (1.79) | 0 (0) | |
| Sport score (median (Q1,Q3)) | 3 (2,4) | 3 (2.4) | 0.965 (0.961, − 0.968) |
| BSME holding time (seconds) (mean, (SD)) | 164.64 (50.61) | 189.60 (46.65) |
Displayed are significance (P), 95% confidence intervals (95% CI), lower limit (LL) and upper limit (UL).
Significant values are in bold.
Figure 2Muscle oxygenation of M. longissimus and M. multifidus of a representative asymptomatic subject (a) and a representative CNSLBP patient (b) before (0–2 min), during (2 to maximal 6 min) and after execution of the Biering–Sorensen muscle endurance (BSME) test. The green lines indicate the start and the end of the BSME test.
Results of the unpaired t-tests of the unstandardized residuals (corrected SmO2) for area under the curve (AUC) and medians of NIRS measurements of M. longissimus and M. multifidus in chronic nonspecific low back pain subjects (CNSLBP) and asymptomatic controls.
| Variables | Mean CNSLBP patients (SD) | Mean asymptomatic controls (SD) | Significance ( |
|---|---|---|---|
AUC (SmO2) | − 193.71 (4148.23) | − 276.50 (4361.66) | 0.936 (− 1963.68, 2129.26) |
AUC (SmO2) | − 272.18 (3086.92) | − 77.55 (2633.75) | 0.792 (− 1664.68, 1275.43) |
Median 1 (SmO2) | − 2.90 (23.13) | 0.00 (21.98) | 0.591 (− 13.67, 7.85) |
Median 1 (SmO2) | − 2.43 (17.45) | 0.43 (18.17) | 0.531 (− 11.97, 6.23) |
Median 2 (SmO2) | − 2.08 (23.54) | − 0.99 (22.79) | 0.852 (− 12.67, 10.50) |
Median 2 (SmO2) | − 2.05 (17.69) | 0.29 (15.10) | 0.591 (− 11.07, 6.36) |
Median 3 (SmO2) | − 1.74 (24.89) | − 1.75 (23.39) | 0.998 (− 10.95, 10.99) |
Median 3 (SmO2) | − 0.73 (15.47) | − 0.78 (16.87) | 0.990 (− 7.34, 7.44) |
Displayed are the mean, significance and 95% confidence intervals, lower limit (LL) and upper limit (UL).
Results of the unpaired t-test of the unstandardized residuals (corrected SmO2) for area under the curve (AUC) and medians of oxygenation of the M. longissimus and M. multifidus in chronic nonspecific low back pain subjects (CNSLBP) with pain ratings above 2 and asymptomatic controls.
| Variables | Mean CNSLBP patients (pain intensity above 2) | Mean asymptomatic controls | Significance ( |
|---|---|---|---|
AUC (SmO2) | 715.32 (3097.27) | − 1101.59 (4840.35) | 0.194 (− 976.33, 4610.17) |
AUC (SmO2) | − 458.23 (2967.43) | − 914.42 (3157.92) | 0.678 (− 1764.52, 2676.91) |
Median 1 (SmO2) | 1.11 (17.21) | − 1.47 (25.07) | 0.723 (− 12.51, 17.33) |
Median 1 (SmO2) | − 4.35 (17.86) | − 3.71 (20.49) | 0.926 (− 14.50, 13.22) |
Median 2 (SmO2) | 1.14 (19.33) | − 4.15 (24.52) | 0.513 (− 11.02, 21.61) |
Median 2 (SmO2) | − 6.01 (18.99) | − 4.14 (16.55) | 0.783 (− 15.71, 11.97) |
Median 3 (SmO2) | 2.95 (17.91) | − 3.87 (25.92) | 0.344 (− 7.61, 21.27) |
Median 3 (SmO2) M. multifidi (%) | − 4.14 (15.57) | − 1.09 (17.67) | 0.575 (− 14.01, 7.90) |
Displayed are the mean, significance (P) and 95% confidence intervals, lower limit (LL) and upper limit (UL).
Multiple regression results for BSME shown for Median 3.
| BSME | B | 95% CI for B | SE B | β | R2 | ΔR2 | Sig |
|---|---|---|---|---|---|---|---|
| Model | 0.372 | 0.248 | 0.003 | ||||
| Constant | 243.643 | 139.80 to 347.482 | 51.835 | ||||
| Pain intensity | − 6.090 | − 14.723 to 2.542 | 4.309 | − 0.245 | 0.163 | ||
| Group | − 1.205 | − 33.305 to 30.894 | 16.024 | − 0.013 | 0.940 | ||
| Age | 0.784 | − 0.210 to 1.778 | 0.496 | 0.199 | 0.120 | ||
| BMI | − 7.028 | − 11.127 to − 2.929 | 2.046 | − 0.412 | |||
| Sex | 1.928 | − 22.192 to 26.047 | 12.040 | 0.020 | 0.873 | ||
| Sport score | 14.759 | 2.157 to 27.360 | 6.291 | 0.264 | |||
Residual Median 3 | 0.174 | − 0.264 to 0.611 | 0.218 | 0.089 | 0.430 | ||
Residual Median 3 | 0.052 | − 0.618 to 0.721 | 0.334 | 0.018 | 0.878 | ||
| Pulse pressure | 0.034 | − 1.225 to 1.293 | 0.628 | 0.012 | 0.957 | ||
| Mean arterial pressure | 0.230 | − 1.968 to 2.427 | 1.097 | 0.052 | 0.835 | ||
| Heart rate | 0.457 | − 0.279 to 1.193 | 0.367 | 0.195 | 0.219 |
Displayed are B = unstandardized regression coefficient, CI = confidence interval, SE B = standard error of the coefficient, β = standardized coefficient, R2 = coefficient of determination, ΔR2 = adjusted R2 and Sig. = significance.
Significant values are in bold.